A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

NCT04796623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

HR-positive, HER2-negative Advanced Breast Cancer

Interventions

DRUG: TQB3616 capsules
DRUG: Fulvestrant injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.